Yayın:
The efficacy and safety of ct-p13 as first-line and subsequent-line therapy in patients with ankylosing spondylitis: Real-life data from Turkbio cohort

dc.contributor.authorUslu, Sadettin
dc.contributor.authorGülle, Semih
dc.contributor.authorCan, Gerçek
dc.contributor.authorŞenel, Soner
dc.contributor.authorÇapar, Sedat
dc.contributor.authorAkar, Servet
dc.contributor.authorKoca, Süleyman Serdar
dc.contributor.authorTufan, Abdurrahman
dc.contributor.authorYazıcı, Ayten
dc.contributor.authorYılmaz, Sema
dc.contributor.authorInanç, Nevşün
dc.contributor.authorBirlik, Merih
dc.contributor.authorSolmaz, Dilek
dc.contributor.authorCefle, Ayşe
dc.contributor.authorGöker, Berna
dc.contributor.authorYolbaş, Servet
dc.contributor.authorKrough, Niels Steen
dc.contributor.authorYılmaz, Neslihan
dc.contributor.authorErten, Şükran
dc.contributor.authorBeş, Cemal
dc.contributor.authorSoysal, Özgül
dc.contributor.authorÖztürk, Mehmet Akif
dc.contributor.authorHaznedaroğlu, Seminur
dc.contributor.authorYavuz, Şule
dc.contributor.authorDireşkeneli, Haner
dc.contributor.authorÖnen, Fatoş
dc.contributor.authorSarı, İsmail
dc.contributor.buuauthorDalkılıç, Hüseyin Ediz
dc.contributor.buuauthorDALKILIÇ, HÜSEYİN EDİZ
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.researcheridERI-0246-2022
dc.date.accessioned2024-12-02T05:48:28Z
dc.date.available2024-12-02T05:48:28Z
dc.date.issued2022-09-01
dc.descriptionBu çalışma, 10-14 Kasım 2022tarihleri arasında Philadelphia[Amerika Birleşik Devletleri ]’da düzenlenen Annual Meeting of the American-College-of-Rheumatology (ACR)’da bildiri olarak sunulmuştur.
dc.description.sponsorshipAmer Coll Rheumatol
dc.identifier.endpage849
dc.identifier.issn2326-5191
dc.identifier.issueSupplement 9, Special Issue SI
dc.identifier.startpage847
dc.identifier.urihttps://hdl.handle.net/11452/48739
dc.identifier.volume74
dc.identifier.wos000877386500424
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherWiley
dc.relation.journalArthritis & Rheumatology
dc.relation.publicationcategoryKonferans Öğesi – Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectRheumatology
dc.titleThe efficacy and safety of ct-p13 as first-line and subsequent-line therapy in patients with ankylosing spondylitis: Real-life data from Turkbio cohort
dc.typeOther
dc.type.subtypeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.indexed.atWOS
relation.isAuthorOfPublication1613225c-2f43-4052-9f82-210c854edcf4
relation.isAuthorOfPublication.latestForDiscovery1613225c-2f43-4052-9f82-210c854edcf4

Dosyalar